Earnings Preview: ADPT to Report Financial Results Post-market on May 01

Moomoo NewsApr 25 21:00 ET

Cathie Wood Buys More NVIDIA And AMD Stock As Chinese Tech Giants Stockpile Chips Amid Looming US Export Curbs

BenzingaApr 23 21:23 ET

$ADPT Stock Is up 8% Today. Here's What We See in Our Data.

Quiver QuantitativeApr 23 11:31 ET

Is Adaptive Biotechnologies (NASDAQ:ADPT) Using Debt Sensibly?

Simply Wall StApr 13 09:40 ET

Adaptive Biotechnologies to Report First Quarter 2025 Financial Results on May 1, 2025

GlobeNewswireApr 10 16:05 ET

Express News | Adaptive Biotechnologies Shares Are Trading Higher After the Company Announced That Palmetto GBA Expanded Its Coverage of CloneSEQ

BenzingaApr 8 09:27 ET

Express News | Adaptive Biotechnologies Receives Expanded Medicare Coverage of Clonoseq® for Surveillance in Mantle Cell Lymphoma

ReutersApr 8 08:01 ET

Adaptive Biotechnologies Receives Expanded Medicare Coverage of ClonoSEQ for Surveillance in Mantle Cell Lymphoma

GlobeNewswireApr 8 08:00 ET

Guess, Tesla, Nvidia And Other Big Stocks Moving Lower In Friday's Pre-Market Session

BenzingaApr 4 08:16 ET

Why Sangamo Therapeutics Shares Are Trading Higher By Around 40%; Here Are 20 Stocks Moving Premarket

BenzingaApr 4 05:20 ET

12 Health Care Stocks Moving In Wednesday's After-Market Session

BenzingaApr 2 17:05 ET

$ADPT Stock Is up 3% Today. Here's What We See in Our Data.

Quiver QuantitativeApr 2 11:31 ET

TD Cowen Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Maintains Target Price $10

Moomoo NewsMar 31 07:31 ET · Ratings

Analysts Offer Insights on Healthcare Companies: Siemens Healthineers AG (OtherSEMHF), Adaptive Biotechnologies (ADPT) and Alnylam Pharma (ALNY)

TipRanksMar 31 06:50 ET · Ratings

Insider Sale: Chief Scientific Officer of $ADPT Sells 1,698 Shares

Quiver QuantitativeMar 26 19:00 ET

Goldman Sachs Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Maintains Target Price $9

Moomoo NewsMar 24 07:31 ET · Ratings

Scholastic Posts Strong Earnings, Joins Ouster, Torrid Holdings, Adaptive Biotechnologies And Other Big Stocks Moving Higher On Friday

BenzingaMar 21 10:29 ET

Goldman Sachs Upgrades Adaptive Biotechnologies(ADPT.US) to Buy Rating, Raises Target Price to $9

Moomoo NewsMar 21 07:33 ET · Ratings

Goldman Sachs Upgrades Adaptive Biotechnologies to Buy From Neutral, Adjusts Price Target to $9 From $8

MT NewswiresMar 21 07:16 ET · Ratings

Adaptive Biotechnologies (ADPT): Among Stocks Insiders Are Selling In March

Yahoo FinanceMar 20 15:06 ET